Free Float 39,23 %
Shares Float 212,84 M
Shares Outstanding 542,57 M
ADVANCED ONCOTHER.
Share · GB00BD6SX109 · A2AL9X (XLON)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ADVANCED ONCOTHER.
No Price
Share Float & Liquidity
Company Profile for ADVANCED ONCOTHER. Share
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Company Data
Name ADVANCED ONCOTHER.
Company Advanced Oncotherapy plc
Website
https://www.avoplc.com
Primary Exchange 
London
London
WKN A2AL9X
ISIN GB00BD6SX109
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Nicolas Serandour
Country United Kingdom
Currency GBP
Employees 0,2 T
Address 4 Tenterden Street, W1S 1TE London
IPO Date 2006-08-04
Stock Splits
| Date | Split |
|---|---|
| 01.07.2016 | 1:25 |
Ticker Symbols
| Name | Symbol |
|---|---|
| London | AVO.L |
More Shares
Investors who hold ADVANCED ONCOTHER. also have the following shares in their portfolio:
